HTG MOLECULAR DIAGNOSTICS, INC Annual Net Income (Loss) Attributable to Parent in USD from 2014 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Htg Molecular Diagnostics, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2022.
  • Htg Molecular Diagnostics, Inc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2023 was -$5.05M, a 22.2% increase year-over-year.
  • Htg Molecular Diagnostics, Inc Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2023 was -$20.2M, a 7.22% decline year-over-year.
  • Htg Molecular Diagnostics, Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$21.6M, a 26% decline from 2021.
  • Htg Molecular Diagnostics, Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$17.1M, a 17.8% increase from 2020.
  • Htg Molecular Diagnostics, Inc annual Net Income (Loss) Attributable to Parent for 2020 was -$20.9M, a 8.15% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$21.6M -$4.45M -26% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2021 -$17.1M +$3.73M +17.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$20.9M -$1.57M -8.15% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 -$19.3M -$2.84M -17.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 -$16.5M +$2.51M +13.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-25
2017 -$19M +$7.08M +27.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 -$26M -$4.64M -21.7% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-23
2015 -$21.4M -$7.44M -53.3% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-23
2014 -$14M Jan 1, 2014 Dec 31, 2014 10-K 2016-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.